Gefticip Gefitinib 250mg Tablet 30's
Manufacturer: CIPLA LTD
Salt: GEFITINIB 250MG
Category: Anti-Cancer
Price: $53
Availability: In Stock
Gefticip 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.
Some formulations of this drug may contain lactose as an inactive ingredient, which the body is unable to digest. Lactose is a sugar found in milk and dairy products. It can cause symptoms such as bloating and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.
Consult your doctor before using this medication if you are pregnant or plan to have a baby. These tablets are unsafe to use during pregnancy as they cause harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this tablet. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose.
Non-small cell lung cancer.
Gefticip Gefitinib 250mg Tablet 30's
Product Information
What is Gefticip Gefitinib 250mg Tablet 30's?
Gefticip 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.
Some formulations of this drug may contain lactose as an inactive ingredient, which the body is unable to digest. Lactose is a sugar found in milk and dairy products. It can cause symptoms such as bloating and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.
Consult your doctor before using this medication if you are pregnant or plan to have a baby. These tablets are unsafe to use during pregnancy as they cause harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this tablet. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose.
Indications for Gefticip Gefitinib 250mg Tablet 30's
Non-small cell lung cancer.
Therapeutic Effects of Gefticip Gefitinib 250mg Tablet 30's
It is an anilino quinazoline derivative which interacts with a kinase inhibitor that inhibits an abnormal protein called the epidermal growth factor receptor (EGFR). This helps to slow or stop the growth of cancer cells and reduce the size of tumors in patients with NSCLC.
How to consume Gefticip Gefitinib 250mg Tablet 30's
The medicine will be prescribed to you by a healthcare professional in a hospital setting. Gefticip 250mg Tablet is available as a tablet to be taken with or without food, as directed by your healthcare provider. The usual recommended dosage is 250 mg tablet once daily. Avoid crushing, opening, or dissolving the tablet, swallow it whole with a glass of water. Take this tablet at the same time every day.
Side Effects of Gefticip Gefitinib 250mg Tablet 30's
Diarrhea
Nausea
Vomiting
Loss of appetite
Weakness
Red or sore mouth
Increased liver enzymes
Itchy or cracked skin
Dry mouth
Red or itchy eyes
Nail problems
Hair loss
Fever
Blood in the urine and a burning sensation while urinating
Drug Interactions
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Gefticip 250mg Tablet and reduce effectiveness by causing undesirable side effects.
Storage & Handling
Store Gefticip 250mg Tablet in the original package at room temperature (25°C).
Keep it out of reach from children.
If you have missed any dosing appointments, inform your doctor and schedule immediately.
Expert Advice
Gefticip 250mg Tablet is not recommended for children and adolescents below 18. It is advisable to monitor your blood pressure regularly during this treatment. Avoid high-fiber foods and drink lots of fluids if you have severe diarrhea. Antacids should not be used two hours before or one hour after taking this Tablet. Avoid driving and operating heavy machinery if you feel tired or weak during this treatment.
Worldwide Shipping & Delivery
We provide specialized tracked delivery for Gefticip Gefitinib 250mg Tablet 30's to multiple countries across the globe. Our logistics network ensures temperature-controlled handling for sensitive oncology medications.
- USA Shipping
- UK Delivery
- UAE & Middle East
- Germany & EU
- Australia
- Canada
Professional Safety Guidelines for Gefticip Gefitinib 250mg Tablet 30's

Pregnancy
UnsafeIt is unsafe to use during pregnancy whether Gefticip 250mg Tablet can be taken during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.

BreastFeeding
UnsafeIt is unsafe to breastfeed during the treatment with this Gefticip 250mg Tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.

Liver
Consult your doctorIt is unknown whether Gefticip 250mg Tablet can be used for patients with liver disorders. Inform your physician if you have any liver problems before starting treatment.

Lungs
Consult your doctorIt is unknown whether Gefticip 250mg Tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Alcohol
Consult your doctorIt is unknown whether consuming alcohol interacts with the Gefticip 250mg Tablet. Please consult your doctor for more advice.

Driving
UnsafeIt is unsafe to drive vehicles or operate heavy machinery after taking the Gefticip 250mg Tablet because it contains a small amount of alcohol which may cause dizziness and impair your concentration.